Inhibiting PD-1 had no effect on the growth of the metastatic lesions formed with control PDA cells but prevented expansion of metastases formed with PDA cells lacking expression of KRT19 or TGM2 (Fig. 6C). The gene discussed is KRT19; the disease is Patent ductus arteriosus.